Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000359 · ClinicalTrials.gov registry record · Phase 2
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
A Phase 2 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00000359: Completed Phase 2 study, sponsored by Baylor College of Medicine.
NCT00000359 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 150 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000359, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.
Interventions
- BEHAVIORAL Canalith repositioning maneuver (Epley maneuver)
- BEHAVIORAL Semont maneuver
- BEHAVIORAL Brandt-Daroff exercises
- BEHAVIORAL Vestibular habituation exercises
- BEHAVIORAL ShamManeuver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1998-10 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
What the finished NCT00000359 record still lists
NCT00000359 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 5 interventions - of which Canalith repositioning maneuver (Epley maneuver) is the first listed.
NCT00000359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000359 about?
NCT00000359 is a clinical study titled "Treatments for Benign Paroxysmal Positional Vertigo (BPPV)". The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, t...
What is the current status of trial NCT00000359?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 1998-10. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00000359?
The interventions under investigation include: Canalith repositioning maneuver (Epley maneuver) (BEHAVIORAL), Semont maneuver (BEHAVIORAL), Brandt-Daroff exercises (BEHAVIORAL), Vestibular habituation exercises (BEHAVIORAL), ShamManeuver (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000359?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000359's enrollment target sits among peer trials
150 455th of 2000 higher than 1,510 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia